Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng-Sheng Yi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Oncology|July 10, 2023
Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysisJun-Ning Liu, Ji-Jiang Li, Shu Yan, et al.
Oncology Letters|September 26, 2018
Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinomaPeng Sheng Yi, Bin Wu, Da Wei Deng, et al.
The Journal of Surgical Research|June 25, 2016
Alvimopan combined with enhanced recovery strategy for managing postoperative ileus after open abdominal surgery: a systematic review and meta-analysisLiang-Liang Xu, Xiao-Qin Zhou, Peng-Sheng Yi, et al.
Journal of Cellular Physiology|May 29, 2019
Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinomaPeng Sheng Yi, Yan Shu, Wang Xiu Bi, et al.
World Journal of Gastrointestinal Oncology|November 24, 2025
Personalized prognosis in unresectable hepatocellular carcinoma: Development and validation of a model for transcatheter arterial chemoembolization plus lenvatinibJia-Hui Yu, Jun Yu, Jin-Xin Yu, et al.
Cancer Science|January 19, 2017
miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liverXiao-Bo Zheng, Xiao-Bo Chen, Liang-Liang Xu, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|December 23, 2017
Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysisLiang-Liang Xu, Ming Zhang, Peng-Sheng Yi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Oncology|July 10, 2023
Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysisJun-Ning Liu, Ji-Jiang Li, Shu Yan, et al.
Oncology Letters|September 26, 2018
Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinomaPeng Sheng Yi, Bin Wu, Da Wei Deng, et al.
The Journal of Surgical Research|June 25, 2016
Alvimopan combined with enhanced recovery strategy for managing postoperative ileus after open abdominal surgery: a systematic review and meta-analysisLiang-Liang Xu, Xiao-Qin Zhou, Peng-Sheng Yi, et al.
Journal of Cellular Physiology|May 29, 2019
Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinomaPeng Sheng Yi, Yan Shu, Wang Xiu Bi, et al.
World Journal of Gastrointestinal Oncology|November 24, 2025
Personalized prognosis in unresectable hepatocellular carcinoma: Development and validation of a model for transcatheter arterial chemoembolization plus lenvatinibJia-Hui Yu, Jun Yu, Jin-Xin Yu, et al.
Cancer Science|January 19, 2017
miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liverXiao-Bo Zheng, Xiao-Bo Chen, Liang-Liang Xu, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|December 23, 2017
Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysisLiang-Liang Xu, Ming Zhang, Peng-Sheng Yi, et al.
Pageof 2